Underuse of ACE inhibitors, beta-blockers and spironolactone in patients with heart failure is primarily due to lack of initiation of treatment

GH Gislason, JN Rasmussen, SZ Abildstrom, P Buch, S Rasmussen, J Friberg, TK Schramm, L Kober, M Madsen, C Torp-Pedersen

OriginalsprogEngelsk
TidsskriftJournal of the American College of Cardiology
Vol/bind47
Udgave nummer4
Sider (fra-til)42A-42A
ISSN0735-1097
StatusUdgivet - 21 feb. 2006

Citationsformater